Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors

Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors

Alexa B Schrock,1 Russell Madison,1 Mark Rosenzweig,2 Justin M Allen,2 Rachel L Erlich,2 Siao-Yi Wang,3 Tarek Chidiac,4 Vodur Suresh Reddy,5 Jonathan W Riess,6 Ahmet Ersin Yassa,6 Abdur Shakir,7 Vincent A Miller,1 Brian M Alexander,1 Jeffrey Venstrom,1 Kimberly McGregor,1 Siraj M Ali1 1Foundation Me...

Full description

Bibliographic Details
Main Authors: Schrock AB, Madison R, Rosenzweig M, Allen JM, Erlich RL, Wang SY, Chidiac T, Reddy VS, Riess JW, Yassa AE, Shakir A, Miller VA, Alexander BM, Venstrom J, McGregor K, Ali SM
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:Lung Cancer : Targets and Therapy
Subjects:
alk rearrangement
inversion
deletion
genomic profiling
targeted therapy
Online Access:https://www.dovepress.com/patients-with-nsclcs-harboring-internal-inversions-or-deletion-rearran-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/patients-with-nsclcs-harboring-internal-inversions-or-deletion-rearran-peer-reviewed-article-LCTT

Similar Items